University of Colorado, Denver: Polycystic Kidney, Autosomal Dominant trials

The registry lists 12 Polycystic Kidney, Autosomal Dominant studies with University of Colorado, Denver as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 2 3Phase 3 2Phase 4 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Glucagon-Like Peptide-1 Receptor Agonist in ADPKDRecruitingNCT06582875Phase 2
• Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT03342742Not applicableResults posted
• Feasibility Study of Metformin Therapy in ADPKDCompletedNCT02903511Phase 2Results posted
• Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKDCompletedNCT02494141Phase 4Results posted
• Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT01853553Phase 3Results posted
• Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)CompletedNCT00456365Phase 3Results posted
• Renal Oxygen Consumption, Insulin Sensitivity, and Daily Caloric Restriction in ADPKDActive, not recruitingNCT06496542Not applicable
• Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney DiseaseActive, not recruitingNCT05510115Phase 2
• Daily Caloric Restriction in ADPKDActive, not recruitingNCT04907799Not applicable
• Time Restricted Feeding in Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT04534985Not applicable
• PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)CompletedNCT04407481
• Statin Therapy in Patients With Early Stage ADPKDActive, not recruitingNCT03273413Phase 4